Blood Bank Market Set to Experience Striking Growth, Estimated to Cross USD 21.86 billion by 2027
High prevalence of hematologic diseases, rise in accidents, and growth in geriatric population drive the global blood bank market.
PORTLAND, OREGON, UNITED STATES, May 15, 2023 /EINPresswire.com/ -- Allied Market Research published a report, titled, "𝐁𝐥𝐨𝐨𝐝 𝐁𝐚𝐧𝐤 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐓𝐲𝐩𝐞 (𝐖𝐡𝐨𝐥𝐞 𝐁𝐥𝐨𝐨𝐝, 𝐑𝐞𝐝 𝐁𝐥𝐨𝐨𝐝 𝐂𝐞𝐥𝐥𝐬, 𝐏𝐥𝐚𝐭𝐞𝐥𝐞𝐭𝐬, 𝐏𝐥𝐚𝐬𝐦𝐚, 𝐚𝐧𝐝 𝐖𝐡𝐢𝐭𝐞 𝐁𝐥𝐨𝐨𝐝 𝐂𝐞𝐥𝐥𝐬), 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧 (𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧, 𝐏𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠, 𝐓𝐞𝐬𝐭𝐢𝐧𝐠, 𝐒𝐭𝐨𝐫𝐚𝐠𝐞, 𝐚𝐧𝐝 𝐓𝐫𝐚𝐧𝐬𝐩𝐨𝐫𝐭𝐚𝐭𝐢𝐨𝐧), 𝐁𝐚𝐧𝐤 𝐓𝐲𝐩𝐞 (𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐚𝐧𝐝 𝐏𝐮𝐛𝐥𝐢𝐜), 𝐚𝐧𝐝 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥, 𝐀𝐦𝐛𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐂𝐞𝐧𝐭𝐞𝐫𝐬, 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬, 𝐂𝐥𝐢𝐧𝐢𝐜𝐬 & 𝐍𝐮𝐫𝐬𝐢𝐧𝐠 𝐇𝐨𝐦𝐞𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟐𝟎–𝟐𝟎𝟐𝟕." According to the report, the global 𝐁𝐥𝐨𝐨𝐝 𝐁𝐚𝐧𝐤 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 was Valued at 𝐔𝐒𝐃 𝟏𝟑.𝟖𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟏𝟗 and is Projected to Garner 𝐔𝐒𝐃 𝟐𝟏.𝟖𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟕, registering a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟕% from 2020 to 2027.
This report provides a comprehensive overview of the Blood Bank Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the Blood Bank Market and its growth potential in the future.
High prevalence of hematologic diseases, rise in accidents, and growth in the geriatric population drive the growth of the global blood bank market. However, wastage of donated blood and stringent rules and regulations hinder market growth. On the other hand, growth in blood transfusion in emerging nations creates new opportunities in the coming years.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/5048
𝐓𝐨𝐩 𝐁𝐥𝐨𝐨𝐝 𝐁𝐚𝐧𝐤 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
• The American Red Cross • Vitalant • New York Blood Centre • Australian Red Cross • Japan Red Cross Society • American Association of Blood Banks • America's Blood Centers • Canadian Blood Services • Sanquin Blood Supply Foundation • Blood Bank of Alaska
𝐁𝐥𝐨𝐨𝐝 𝐁𝐚𝐧𝐤 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
Based on product type, the red blood cell segment accounted for nearly two-fifths of the global blood bank market in 2019, and is expected to maintain its lead status in terms of revenue throughout the forecast period. This is due to high demand for transfusion of red blood cells over whole blood in patients suffering from anemia. In addition, rise in demand of red blood cell for cases of excessive bleeding due to trauma, surgery or childbirth further augments the growth of the segment. However, the platelet segment is estimated to portray the highest CAGR of 7.5% from 2020 to 2027, owing to high prevalence of dengue in tropical countries and increase in the adoption of modern treatment of hypo proliferative thrombocytopenia.
Based on function, the testing segment contributed to the highest market share with nearly one-third of the global blood bank market in 2019, and is estimated to maintain its leadership position during the forecast period. This is attributed to high cost of screening tests of blood and its components as well as large number of diagnostic tests that are conducted during processing of blood. However, the collection segment is estimated to generate the fastest CAGR of 6.7% from 2020 to 2027. This is attributed to increase in demand for blood transfusion and rise in prevalence of haematological diseases globally.
Based on region, Europe accounted for the highest share based on revenue, holding for more than one-third of the global blood bank market in 2019, and is projected to maintain its dominant position throughout the forecast period. This is attributed to the well-established healthcare infrastructure, large number of diagnosed patients, rise in number of blood donations, and supportive healthcare policies. However, Asia-Pacific is estimated to portray the fastest CAGR of 6.4% from 2020 to 2027, owing to increase in demand for blood transfusion and introduction of supportive reimbursement policies by the healthcare system. In addition, North America is anticipated to register a CAGR of 5.0% during the forecast period.